Gillibrand Co-Sponsors Bill to Accelerate FDA Approval of Drugs to Treat Life-Threatening Illnesses

New York's junior senator has announced a bipartisan bill that would expedite provisional FDA approval of drugs intended to treat ALS, Parkinson's, Alzheimer's, and other life-threatening diseases. Kirsten Gillibrand is a co-sponsor of the Promising Pathway Act. During a video conference call with reporters on Wednesday, Gillibrand said the standard FDA approval process takes many years to get drugs to market...

Kirsten Gillibrand: need to accelerate approval of promising drugs

The legislation is being co-sponsored by Indiana Republican Mike Braun. Republican Representative Mike Gallagher of Wisconsin and Democratic Representative Mike Quigley of Illinois are introducing companion legislation in the House.